UNSPSC 51101690: Teclozan

This classification denotes a benzylamine and acetamide with the molecular formula C20H28Cl4N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K9RIF0COUB, chemically known as 2,2-dichloro-n-(4-(((dichloroacetyl)(2-ethoxyethyl)amino)methyl)benzyl)-n-(2-ethoxyethyl)acetamide but generally known as teclozan, which bears US NIH Compound Identifier 21723. European Medicines Agency schedules Teclozan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10863MIG.

UNSPSC 51101690 Teclozan, a Commodity code, represents pharmaceutical products and related medical supplies that state and local governments procure for public health and emergency response programs. Recent solicitations show state and local agencies buying naloxone and drug deactivation systems, generic pharmaceuticals through cooperative purchasing agreements, and medical first aid supplies for fire and rescue divisions. The work spans acquisition of finished pharmaceutical products, OTC medications, and emergency medical consumables—not manufacturing or compounding—with vendors supplying through established wholesaler networks or direct delivery to government health and emergency-response facilities.

Activity under the code comes from state health departments, county public health agencies, city fire departments, and cooperative purchasing alliances serving multiple jurisdictions. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, appears as a repeat buyer organizing multi-state procurement for generic pharmaceuticals and OTC products. Seminole County, Florida; the City of Tampa; and the Texas Health and Human Services Commission have posted recent opportunities. Geographic spread includes Florida, Texas, and Minnesota with participation from Oregon through MMCAP's multi-state agreement. Representative recent opportunities include Seminole County's IFB (due July 26, 2023) for 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly deliveries to its Community Health Building; the City of Tampa's invitation to bid (due March 13, 2026, estimated value $700,000.00) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, sheltered for certified Small Local Business Enterprises with a 5 percent bid discount; and MMCAP's RFP (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across state and local facilities, with awards effective July 1, 2026 and pricing weighted 75 percent on competitiveness.